409 related articles for article (PubMed ID: 25266556)
1. Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.
Attwa E; Khater M; Assaf M; Haleem MA
Int J Dermatol; 2015 Feb; 54(2):235-44. PubMed ID: 25266556
[TBL] [Abstract][Full Text] [Related]
2. Erbium:YAG laser resurfacing for refractory melasma.
Manaloto RM; Alster T
Dermatol Surg; 1999 Feb; 25(2):121-3. PubMed ID: 10037517
[TBL] [Abstract][Full Text] [Related]
3. Melasma: histopathological characteristics in 56 Korean patients.
Kang WH; Yoon KH; Lee ES; Kim J; Lee KB; Yim H; Sohn S; Im S
Br J Dermatol; 2002 Feb; 146(2):228-37. PubMed ID: 11903232
[TBL] [Abstract][Full Text] [Related]
4. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
[TBL] [Abstract][Full Text] [Related]
5. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma.
Grimes PE; Yamada N; Bhawan J
Am J Dermatopathol; 2005 Apr; 27(2):96-101. PubMed ID: 15798432
[TBL] [Abstract][Full Text] [Related]
6. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
Moubasher AE; Youssef EM; Abou-Taleb DA
Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
[TBL] [Abstract][Full Text] [Related]
8. Histologic and ultrastructural analysis of melasma after fractional resurfacing.
Goldberg DJ; Berlin AL; Phelps R
Lasers Surg Med; 2008 Feb; 40(2):134-8. PubMed ID: 18306153
[TBL] [Abstract][Full Text] [Related]
9. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma.
Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST
J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754
[TBL] [Abstract][Full Text] [Related]
11. Treatment of melasma using variable square pulse Er:YAG laser resurfacing.
Wanitphakdeedecha R; Manuskiatti W; Siriphukpong S; Chen TM
Dermatol Surg; 2009 Mar; 35(3):475-81; discussion 481-2. PubMed ID: 19250309
[TBL] [Abstract][Full Text] [Related]
12. Treatment of melasma with the 1,927-nm fractional thulium fiber laser: a retrospective analysis of 20 cases with long-term follow-up.
Niwa Massaki AB; Eimpunth S; Fabi SG; Guiha I; Groff W; Fitzpatrick R
Lasers Surg Med; 2013 Feb; 45(2):95-101. PubMed ID: 23255085
[TBL] [Abstract][Full Text] [Related]
13. Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment.
Gao YL; Jia XX; Wang M; Hua Y; Zheng H; Xiang WZ; Song XZ
Lasers Med Sci; 2019 Jun; 34(4):767-771. PubMed ID: 30302596
[TBL] [Abstract][Full Text] [Related]
14. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
15. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study.
Miot LD; Miot HA; Polettini J; Silva MG; Marques ME
Am J Dermatopathol; 2010 Oct; 32(7):676-82. PubMed ID: 20534990
[TBL] [Abstract][Full Text] [Related]
16. Comparison of surgical stripping; erbium-doped:yttrium, aluminum, and garnet laser; and carbon dioxide laser techniques for gingival depigmentation: a clinical and histologic study.
Hegde R; Padhye A; Sumanth S; Jain AS; Thukral N
J Periodontol; 2013 Jun; 84(6):738-48. PubMed ID: 23003920
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA
Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146
[TBL] [Abstract][Full Text] [Related]
18. Fractional versus ablative erbium:yttrium-aluminum-garnet laser resurfacing for facial rejuvenation: an objective evaluation.
El-Domyati M; Abd-El-Raheem T; Abdel-Wahab H; Medhat W; Hosam W; El-Fakahany H; Al Anwer M
J Am Acad Dermatol; 2013 Jan; 68(1):103-12. PubMed ID: 23110966
[TBL] [Abstract][Full Text] [Related]
19. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
[TBL] [Abstract][Full Text] [Related]
20. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis.
Mun JY; Jeong SY; Kim JH; Han SS; Kim IH
J Electron Microsc (Tokyo); 2011; 60(1):11-8. PubMed ID: 20937709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]